The blood-brain barrier protects the brain from poisons but also prevents drugs from reaching brain tumors; innovative new treatments are needed.
This laboratory study shows that a nanotechnology drug called SapC-DOPS crosses that barrier and targets brain-tumor cells and retards growth of tumor blood vessels. The findings also show how the agent targets tumor cells and recommend its further development as a novel treatment for glioblastoma.
An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The laboratory and animal study also shows how the agent, called SapC-DOPS, targets tumor cells and blood vessels. The findings support further development of the drug as a novel treatment for brain tumors.
Glioblastoma multiforme is the most common and aggressive form of brain cancer, with a median survival of about 15 months. A major obstacle to improving treatment for the 3,470 cases of the disease expected in the United States this year is the blood-brain barrier, the name given to the tight fit of cells that make up the blood vessels in the brain. That barrier protects the brain from toxins in the blood but also keeps drugs in the bloodstream from reaching brain tumors.
“Few drugs have the capacity to cross the tumor blood-brain barrier and specifically target tumor cells,” says principal investigator Balveen Kaur, PhD, associate professor of neurological surgery and chief of the Dardinger Laboratory of Neurosciences at the OSUCCC – James. “Our preclinical study indicates that SapC-DOPS does both and inhibits the growth of new tumor blood vessels, suggesting that this agent could one day be an important treatment for glioblastoma and other solid tumors.”
The findings were published in a recent issue of the journal Molecular Therapy.
SapC-DOPS (saposin-C dioleoylphosphatidylserine), is a nanovesicle drug that has shown activity in glioblastoma, pancreatic cancer and other solid tumors in preclinical studies. The nanovesicles fuse with tumor cells, causing them to self-destruct by apoptosis.
Key findings of the study, which used two brain-tumor models, include:
The Latest Bing News on:
SapC-DOPS
- Registration open for the Society for Academic Primary Care Annual Scientific Meeting 2024on April 11, 2024 at 8:25 am
You can now register for this year’s Society for Academic Primary Care Annual Scientific Meeting (SAPC ASM) , which is being held at the University of Bristol on 3-5 July. The conference will welcome ...
- Global Screen Reveals Further International Sales of Spy Thriller ‘Davos 1917’ at MipTV (EXCLUSIVE)on April 10, 2024 at 3:01 am
The co-writer is Thomas Hess, Julia Penner and Michael Sauter. The DOPs are Tobias Dengler and Timon Schäppi. It is produced by Contrast Film (Ivan Madeo, Stefan Eichenberger, Urs Frey ...
- Will Nikita Kucherov be suspended for his hit on Kaiden Guhle? NHL insider provides latest updateon April 5, 2024 at 12:49 pm
The Department of Player Safety (DoPS) has been vigilant in addressing dangerous plays, and Kucherov's hit on Guhle is likely to come under scrutiny. NHL insider Eric Engels' fresh update hints ...
- "Take more beatings now than I did on ice": DoPS senior VP George Parros on the pressure faced from his most recent suspensionson March 20, 2024 at 8:16 am
It's a great chance for us to get together on the same page. Parros has been leading the department for seven years. He assured GMs that the DoPS is committed to ensuring player safety in the NHL.
- Flyers' Danny Briere Says The Department Of Player Safety Was Discussed At GM Meetingson March 18, 2024 at 7:16 pm
The DoPS has long been a topic of discussion and frustration amongst NHL fans. While every fan, person, and general manager is entitled to their opinion, it almost feels like whatever DoPS decides ...
- The Dopson January 5, 2023 at 11:48 pm
Arrived Homes is an alternative investment platform that allows individuals to easily invest in real estate by purchasing shares of rental properties. Investors on the platform earn passive income ...
- Academic Senateon June 12, 2022 at 10:20 am
Academic Policies Committee (APC) - Nancy Haskell Faculty Affairs Committee (FAC) - Art Busch Student Academic Policies Committee (SAPC) - Tim Gabrielli ...
- Six tips to better understand supplemental discipline in the NHLon October 16, 2016 at 5:00 pm
That couldn't be further from the truth, however. During the 2014-15 season I visited the NHL DOPS war room and learned everything I could about how suspensions happen. I've spent the next couple ...
The Latest Google Headlines on:
SapC-DOPS
[google_news title=”” keyword=”SapC-DOPS” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Nanotechnology drug
- Cow's milk particles unlock one of medicine’s most challenging puzzleson April 26, 2024 at 12:47 am
Cow’s milk contains nanoparticles that can be used to deliver disease-modifying RNA therapy orally, according to a new study. With RNA-based drugs currently only administrable by injection, the ...
- Learning from caterpillars to create self-assembling capsules for drug deliveryon April 25, 2024 at 5:00 pm
The researchers are applying for a patent for their innovation, based on their study findings that were reported in Nature Nanotechnology ("Self-assembly of peptide nanocapsules by a solvent ...
- Ultrasensitive photonic crystal detects single particles down to 50 nanometerson April 24, 2024 at 12:49 pm
Using an ultrasensitive photonic crystal, TU/e researchers were able to detect single particles down to 50 nanometers in diameter. The new research has just been published in the journal Optica.
- Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugson April 23, 2024 at 2:43 pm
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant ...
- Breakthrough rice bran nanoparticles show promise as affordable and targeted anticancer agenton April 23, 2024 at 10:45 am
Plant-derived nanoparticles have demonstrated significant anticancer effects. Researchers recently developed rice bran-derived nanoparticles (rbNPs) that efficiently suppressed cell proliferation and ...
- Nanoparticles Derived from Waste Product Effectively Target Cancer Cellson April 23, 2024 at 10:00 am
Researchers from Tokyo University of Science (TUS) have developed nanoparticles from rice bran which demonstrated potent anticancer effects in mice models.
- Nanotechnology Market to Surpass USD 53.51 Billion by 2031 | SkyQuest Technologyon April 23, 2024 at 8:43 am
SkyQuest projects that the nanotechnology market will attain a value of USD 53.51 billion by 2031, with a CAGR of 36.4% over the forecast period (2024-2031). The increasing demand for nanotechnology ...
- Nanoparticles Deliver Drugs Directly Across the Blood-Brain Barrieron April 22, 2024 at 9:02 am
Recent studies published in Nature Communications by an international team of scientists from Michigan State University showed that nanoparticles can traverse the digestive system and deliver ...
- Engineering Powerful Vaccines with Lipid Nanotechnologyon April 21, 2024 at 6:15 am
In this, lipid nanoparticle (LNP) technology has emerged as highly promising. Progress in medical science has facilitated the seamless integration of lipid nanotechnology into standard therapy, ...
- Nanotechnology Market worth $189.39 billion by 2028, at a CAGR of 14.10% - IndustryARCon April 17, 2024 at 5:05 pm
According to the latest Market research report on the Nanotechnology Market, published by IndustryARC, the Nanotools segment is estimated to experience the fastest CAGR of 18.63% during the forecast ...
The Latest Google Headlines on:
Nanotechnology drug
[google_news title=”” keyword=”nanotechnology drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]